1. Real-World Efficacy and Safety of Ritonavir-Boosted Paritaprevir, Ombitasvir, Dasabuvir ± Ribavirin for Hepatitis C Genotype 1 – Final Results of the REV1TAL Study. Issue 8 (November 2017) Authors: Lubel, John; Strasser, Simone; Stuart, Katherine A; Dore, Gregory; Thompson, Alexander; Pianko, Stephen; Bollipo, Steven; Mitchell, Joanne L; Fragomeli, Vincenzo; Jones, Tracey; Chivers, Sarah; Gow, Paul; Iser, David; Levy, Miriam; Tse, Edmund; Gazzola, Alessia; Cheng, Wendy; Nazareth, Saroj; Gal... Journal: Antiviral therapy Issue: Volume 22:Issue 8(2017) Page Start: 699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survival. (2nd November 2018) Authors: Roberts, Stuart K.; Gazzola, Alessia; Lubel, John; Gow, Paul; Bell, Sally; Nicoll, Amanda; Dev, Anouk; Fink, Michael A.; Sood, Siddharth; Knight, Virginia; Hong, Thai; Paul, Eldho; Mishra, Gauri; Majeed, Ammar; Kemp, William Journal: Scandinavian journal of gastroenterology Issue: Volume 53:Number 10/11(2018) Page Start: 1368 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗